UK Companies House feature
WILD COSMETICS LIMITED
Cash
£4M
+194.4% vs 2020
Net assets
£5M
+187% vs 2020
Employees
20
+300% vs 2020
Profit before tax
—
Period ending 2021-12-31
Profile
- Company number
- 11740984
- Status
- Active
- Incorporation
- 2018-12-24
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 47750
- Hubs
- UK Healthcare
Net assets
3-year trend · vs UK Healthcare median
Accounts
3-year trend · latest 2021-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Turnover | — | — | — | |
| Operating profit | — | — | — | |
| Profit before tax | — | — | — | |
| Net profit | — | — | — | |
| Cash | £32,831 | £1,383,544 | £4,072,767 | |
| Total assets less current liabilities | £102,972 | £1,635,120 | £4,670,459 | |
| Net assets | £517 | £1,615,362 | £4,636,107 | |
| Equity | £517 | £1,615,362 | £4,636,107 | |
| Average employees | 1 | 5 | 20 | |
| Wages | — | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Cooper Parry Group Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “On 1 April 2025, the company completed the sale of the business to Unilever U.K. Holdings Limited acquiring 100% of the share capital. Additionally on 1 April 2025, the company issued 145,788 B Ordinary shares at nominal value £0.00001 each and at a total premium of £1.046.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FRANICH, Annita Alda Eleonore | Director | 2025-07-24 | Jun 1970 | Dutch |
| WAIDA, Isabel Grit, Dr | Director | 2025-07-24 | Dec 1969 | British |
| WINNACK, Jack Andrei Geoffrey | Director | 2025-07-24 | May 1990 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOSTOEN, Koen | Director | 2020-01-28 | 2025-04-01 |
| BOWES-LYON, Charles David | Director | 2018-12-24 | 2025-04-01 |
| SULLIVAN, Joseph | Director | 2025-04-01 | 2025-07-24 |
| WARD, Frederick Peter Neven | Director | 2018-12-24 | 2025-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Unilever U.K. Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-04-01 | Active |
| Mr Frederick Peter Neven Ward | Individual | Shares 25–50%, Voting 25–50% | 2018-12-24 | Ceased 2025-04-01 |
| Mr Charles David Bowes-Lyon | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2018-12-24 | Ceased 2020-09-22 |
Filing timeline
Last 20 of 86 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-02-18 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-12-19 | AD01 | address | change registered office address company with date old address new address |
| 2025-09-29 | AA | accounts | accounts with accounts type full |
| 2025-08-07 | TM01 | officers | termination director company with name termination date |
| 2025-08-07 | AP01 | officers | appoint person director company with name date |
| 2025-08-07 | AP01 | officers | appoint person director company with name date |
| 2025-08-07 | AP01 | officers | appoint person director company with name date |
| 2025-04-25 | RESOLUTIONS | resolution | resolution |
| 2025-04-25 | RESOLUTIONS | resolution | resolution |
| 2025-04-25 | MA | incorporation | memorandum articles |
| 2025-04-25 | SH01 | capital | capital allotment shares |
| 2025-04-25 | SH08 | capital | capital name of class of shares |
| 2025-04-25 | SH10 | capital | capital variation of rights attached to shares |
| 2025-04-15 | TM01 | officers | termination director company with name termination date |
| 2025-04-15 | TM01 | officers | termination director company with name termination date |
| 2025-04-15 | TM01 | officers | termination director company with name termination date |
| 2025-04-15 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-04-15 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2025-04-15 | AP01 | officers | appoint person director company with name date |
| 2025-03-25 | MR04 | mortgage | mortgage satisfy charge full |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory